MOLN - Hot Stocks: ARCE TIGR drop on earnings; TGTX plunges on FDA meeting; MOLN rallies

While Federal Reserve policy and Omicron have dominated trading, earnings news drove movement in a handful of individual stocks in Tuesday's midday action. Arco Platform (NASDAQ:ARCE) and UP Fintech (NASDAQ:TIGR) both declined in the wake of their quarterly reports. TG Therapeutics (NASDAQ:TGTX) also recorded a massive midday slide, giving up two-fifths of its value after regulators planned a meeting regarding the firm's cancer therapy. Checking in on the COVID front, Molecular Partners (NASDAQ:MOLN) got a boost in intraday action after it reported signals that its ensovibep showed potential versus the Omicron variant. Decliners Arco Platform (ARCE) recorded an intraday loss of nearly 8% following the release of quarterly results. The Brazil-based educational software company reported a Q3 loss, with revenue plunging 12% from last year. Earnings news also sparked a decline in UP Fintech (TIGR). The China-based brokerage firm reported annual revenue growth of nearly 60%. However, the figure failed

For further details see:

Hot Stocks: ARCE, TIGR drop on earnings; TGTX plunges on FDA meeting; MOLN rallies